FLEXION THERAPEUTICS, INC.

(FLXN)
End-of-day quote. End-of-day quote Nasdaq - 11/18
9.12 USD   -0.22%
03/28Renovacor Names New CFO
MT
2021Pacira BioSciences Logs Higher Exparel, Iovera Sales in November
MT
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
 SummaryQuotesChartsNewsRatingsCompany 
Quotes 5-day view   End-of-day quote. End-of-day quote Nasdaq
11/12/2021 11/15/2021 11/16/2021 11/17/2021 11/18/2021 Date
9.17 9.16 9.15 9.14 9.12 Last
878028 906779 2559406 4136739 18723200 Volume
-0.22% -0.11% -0.11% -0.11% -0.22% Change
Company
Flexion Therapeutics, Inc is a biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), the common form of arthritis. Its product candidate, ZILRETTA, is the intra-articular (IA) injection indicated for the management of OA knee pain. It is approved by Food and... 
More about the company
Ratings of Flexion Therapeutics, Inc.
Trading Rating : 
Investor Rating :  -
ESG Refinitiv : 
-
More Ratings
All news about FLEXION THERAPEUTICS, INC.
03/28Renovacor Names New CFO
MT
2021Pacira BioSciences Logs Higher Exparel, Iovera Sales in November
MT
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
2021Northland Securities Downgrades Flexion Therapeutics to Market Perform From Outperform,..
MT
2021FLEXION THERAPEUTICS INC : Entry into a Material Definitive Agreement, Termination of a Ma..
AQ
2021FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from S&P TMI Index
CI
2021FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from S&P Global BMI Index
CI
2021FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from NASDAQ Composite Index
CI
2021FLEXION THERAPEUTICS, INC.(NASDAQGM : FLXN) dropped from NASDAQ Biotechnology Index
CI
2021FLEXION THERAPEUTICS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION A..
AQ
2021Flexion Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Mont..
CI
2021SHAREHOLDER ALERT : Monteverde & Associates PC Announces an Investigation of Flexion Thera..
PR
2021SHAREHOLDER ALERT : WeissLaw LLP Reminds ADMS, FLXN, AZPN, and EBMT Shareholders About Its..
PR
2021NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
DJ
2021FLEXION THERAPEUTICS : HC Wainwright Downgrades Flexion Therapeutics to Neutral From Buy, ..
MT
More news
News in other languages on FLEXION THERAPEUTICS, INC.
2021Les actions du secteur de la santé en baisse lundi en fin de journée
2021Flexion Therapeutics accepte d'être rachetée par Pacira BioSciences ; les actions s'env..
2021Pacira achète Flexion pour 427,5 millions de dollars
2021Pacira achète Flexion pour 427,5 millions de dollars
2021Earnings Flash (FLXN) FLEXION THERAPEUTICS annonce un chiffre d'affaires de 28,2 millio..
More news
Analyst Recommendations on FLEXION THERAPEUTICS, INC.
More recommendations
Chart FLEXION THERAPEUTICS, INC.
Duration : Period :
Flexion Therapeutics, Inc. Technical Analysis Chart | FLXN | US33938J1060 | MarketScreener
Managers and Directors
Carolyn Beaty Scimemi Chief Compliance Officer & Head-Legal Affairs
Scott A. Young VP-Corporate Communications & Investor Relations
Sector and Competitors
1st jan.Capi. (M$)
FLEXION THERAPEUTICS, INC.0.00%459
GILEAD SCIENCES, INC.-12.93%79 298
REGENERON PHARMACEUTICALS, INC.4.38%71 026
VERTEX PHARMACEUTICALS14.91%64 540
WUXI APPTEC CO., LTD.-19.12%41 409
BIONTECH SE-39.08%38 169